SC

Sahil Chopra

Principal at Vertex Ventures HC

San Francisco, California

Overview 

Sahil Chopra is currently serving as Principal, Investments at Vertex Ventures HC in San Francisco, California, specializing in investing in Series A and Seed stages within sectors such as Medical Devices, Pharmaceuticals, Digital Health, BioTech, and FinTech in the San Francisco Bay Area. With a background in Life Sciences and a Doctor of Philosophy (PhD) from Weill Cornell Graduate School of Medical Sciences, Sahil has progressed through roles from Investment Associate to Vice President of Investments, demonstrating a strong track record of strategic decision-making and leadership in the venture capital industry.

Work Experience 

VV

Vertex Ventures HC

  • Principal

    2024 - Current

  • Vice President of Investments

    2023

  • Senior Associate

    2021

  • Investment Associate

    2019

    Vertex Ventures HC (www.vertexventureshc.com) is part of a global venture fund network under Vertex Venture Holdings, a fund anchored by Temasek Holdings, with offices in Silicon Valley, Boston, and Singapore. Vertex Ventures HC invests globally in various sectors of the healthcare industry, including biotech, biopharmaceuticals, medical devices and digital health with ~$600M under management.

Indapta Therapeutics

  • Board Observer

    2022

EO

Elevation Oncology

  • Board Observer

    2020 - 2021

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.

Raised $197,500,000.00 from K2 HealthVentures.

elevationoncology.com
F

FundRx

  • Venture fellow

    2018 - 2019

The next-generation of healthcare and life science venture capital.

fundrx.com
WC

Weill Cornell Medicine

  • Graduate Student Researcher

    2012 - 2019

    Thesis focused on the stress sensors in the innate-immune cells of the body. Principal investigators- Dr. Laurie Glimcher (Former Dean of Weill Cornell Medicine and Current President at Dana-Farber Cancer Institute, Harvard University) and Dr. Juan Cubillos Ruiz, Cornell University - Published a first author paper in Science - Published as a co-author in Nature and Cell - Over 400 citations

Weill Cornell Medicine is an academic medical institution that offers health care services.

Raised $53,500,000.00 from National Cancer Institute, National Institutes of Health, UnitedHealthcare and National Institutes of Health.

weill.cornell.edu
NI

Net Impact NYC

  • Pro Bono Consultant

    2018 - 2018

    -Provided with a Landscape analysis -Developed a financial model to predict growth of the organization

SCIMALS

  • Analyst

    2015 - 2017

    Provided scientific and market due diligence, business development solutions to clients that include early stage life science investors, healthcare product based companies, healthcare startups

Indian Society of Technical Education (ISTE)

  • General Secretary

    2010 - 2012

    -organize various technical workshops and seminars given by experts

University of Delhi

  • Research Associate

    2011 - 2012

    -Cloning, expression, purification, characterization and computational structural analysis of heme oxygenase enzyme for drug development Principal Investigator- Dr. Suman Kundu

AI

All India Institute of Medical Sciences

  • Intern

    2010 - 2010

    Identification of auto-antibodies for the differentiation of colonic Crohn’s disease from intestinal tuberculosis Principal Investigator- Dr. A. Srinivasan

Education 

Articles About Sahil

Relevant Websites